Supplemental Material, FIgure - Analyzing Upward Deviation of Actual vs Predicted Drug Sales in Japan for a Reasonable Drug-Pricing Policy

Supplemental Material, FIgure for Analyzing Upward Deviation of Actual vs Predicted Drug Sales in Japan for a Reasonable Drug-Pricing Policy by Shoyo Shibata, Daigo Fukumoto, Takeshi Suzuki and Koken Ozaki in Therapeutic Innovation & Regulatory Science